Evelyn Partners Investment Management LLP Novo Nordisk A S Transaction History
Evelyn Partners Investment Management LLP
- $3.52 Trillion
- Q3 2025
A detailed history of Evelyn Partners Investment Management LLP transactions in Novo Nordisk A S stock. As of the latest transaction made, Evelyn Partners Investment Management LLP holds 3,141 shares of NVO stock, worth $151,584. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,141
Previous 4,799
34.55%
Holding current value
$151,584
Previous $190 Million
8.35%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding NVO
# of Institutions
1,697Shares Held
307MCall Options Held
22.6MPut Options Held
30.8M-
Capital International Investors Los Angeles, CA17.7MShares$855 Million0.17% of portfolio
-
Loomis Sayles & CO L P16.2MShares$780 Million1.1% of portfolio
-
Franklin Resources Inc San Mateo, CA14MShares$675 Million0.21% of portfolio
-
Bank Of America Corp Charlotte, NC13.4MShares$647 Million0.05% of portfolio
-
Morgan Stanley New York, NY12.4MShares$599 Million0.04% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $109B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...